GLP-1 drugs Also driving NASH drug development are GLP-1 drugs such as Eli Lillys tirzepatide, marketed in type 2 diabetes as Mounjaro and in obesity as Zepbound
The key consideration is ensuring sufficient subcutaneous fat at the chosen sitethe tissue should be soft and easily pinched to create a fold for injection
If youve been searching for solutions, you might be surprised to learn that GLP-1 agonistsmedications originally designed for diabetes and weight managementcould be a game-changer for perimenopausal symptoms
Every new approval expands the market Better insurance coverage- Right now, many plans dont cover GLP-1s for obesity
After that, any unused medication must be discarded
This post will offer a clear, easy-to-read comparison of three primary weight management strategies: GLP1 drugs, bariatric surgery, and the essential foundation of lifestyle programs